Wednesday, March 20, 2024

NIAID Funding News, March 20, 2024

NIH/NIAID Template Banner

March 20, 2024 NIAID Funding News

Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-03-20

Feature Articles 

Know How to Demonstrate Scientific Progress in Annual Reports

Your program officer will assess the progress, delays, and planned next steps you describe and compare that to your budget request and justification for approval.

Opportunities and Resources

Each award's principal investigator should be an established investigator capable of providing administrative and scientific leadership to the establishment and implementation of a career development program.

A new center will perform activities to coordinate the modeling community through coordinating cores and conduct research projects to advance modeling across and between scales of infectious and immune-mediated disease.

In The News

Join us in our annual appreciation of NIAID peer review and committee members, then learn how to volunteer for a peer review group yourself.

NIAID's TB Portals Program is a global collaboration of clinicians, researchers, and data scientists united in the mission to eradicate tuberculosis.

NIH invites community feedback on upcoming efforts to develop and implement a set of minimum core common data elements for NIH-funded clinical research and trials.

News Briefs and Worth Repeating

  • Attend Research Education Program Webinar on April 4, Apply by June 7
  • Public Access Policy Webpages Are on the Move
  • A Note on the Next NIH Grants Policy Statement Release

Advice Corner

NIH's Office of Research Infrastructure Programs supports purchases of state-of-the-art, commercially available instruments on shared-use basis to enable or enhance cutting-edge research by NIH-funded investigators.

Reader Questions

New Funding Opportunities

  • PAR-24-144, Support for Research Excellence (SuRE) Award (R16, Clinical Trial Not Allowed)
  • PAR-24-145, Support for Research Excellence First Independent Research (SuRE-First) Award (R16, Clinical Trial Not Allowed)
  • RFA-AI-23-077, Center of Excellence for Systems Modeling of Infection and Immunity Across Biological Scales (U54, Clinical Trial Not Allowed)
  • NOT-AI-24-022, Notice of Special Interest (NOSI)—Chemical Countermeasures Research Program (CCRP) Administrative Supplements to Promote the Development of Pediatric Research Models of Chemical Injury and Medical Countermeasures Discovery
  • PA-24-141, NIH Support for Conferences and Scientific Meetings (Parent R13, Clinical Trial Not Allowed)

Find other announcements at NIAID Opportunities and Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment

Give me one week...

Are you ready to "level up" your trading? If you can read one email per day for a week, we can do this -- together...